Skip to Main Content

Paper Details

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer.
Cancer Research
87
2017
CBP, Castration-Resistant Prostate Cancer, androgen, androgen receptor, castration-resistant disease, castration-resistant prostate cancer, p300, prostate cancer, prostate cancers

Datasets